A Prospective, Single-blind, Randomized, Phase III Study to Evaluate the Safety and Efficacy of Fibrin Sealant Grifols05/01/2012 - 12/31/2015 (PI)
Grifols Inc
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers >12 cm^2 to <= 36 cm^210/15/2013 - 08/30/2015 (PI)
HealthPoint Limited
A Non-Interventional Safety Study Providing 12 Months Follow-Up from First Exposure to HP802-247 in Subjects with Venous Leg Ulcer05/01/2012 - 04/30/2015 (PI)
HealthPoint Limited
Observational Study of Tissue Plasminogen Activator Used for Catheter Directed Thrombolysis in Patients with Acute Lower Extremety Native Artery or Bypass Graft Occlusion01/27/2014 - 01/26/2015 (PI)
Grifols Inc
A Phase 3 Randomized, Double Blind, Vehicle Controlled Study Investigating the Safety and Efficacy of HP802-247 in the Treatment of Venous Leg Ulcers05/01/2012 - 04/30/2014 (PI)
HealthPoint Limited
Vital Access Venous Window Needle Guide for salvage of AV Fistulae (SAVE) Trial08/15/2012 - 08/14/2013 (PI)
Vital Access Corp
IN-BALANCE VLU (Inflammation, Bacteria, and Angiogenesis effects in launching venous leg ulcer healing: a clinical evaluation)08/01/2012 - 07/31/2013 (PI)
Celleration, Inc.
A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals
A Phase 2 randomized open label study to evaluate the effects of different intra-thrombus infusion regiments of plasmin humun compared to placebo08/01/2011 - 07/31/2012 (PI)
Talecris Pharmaceuticals
A Phase II Randomized, Double Blind, Placebo Controlled Dose Finding Study Investigating the Efficacy of HP802-247 in Venous Leg Ulcers08/01/2009 - 12/31/2011 (PI)
HealthPoint Limited
Showing 10 of 16 results.
Show All Results
A Phase 2, Randomized, Double-Blind, Placebo-controlled, Parallel-group, Multicenter, Dose-Selection Study of Ad2/Hypoxia Inducible Factor (HIF)-1(alpha)/VP16 in Patients with Intermittent Claudication08/20/2007 - 08/19/2010 (PI)
Genzyme Corporation
Endovascular Repair Using the Talent Abdominal Stent Graft System in Abdominal Aortic Aneurysms02/15/2009 - 02/15/2010 (PI)
Medtronic Inc
Rheos Pivotal Trial: 360009-00105/10/2007 - 05/09/2009 (PI)
CVRx, Inc.
Vascular Sealant System Study02/26/2007 - 10/25/2008 (PI)
Confluent Surgical, Inc.
A Dose Ranging Trial for the Evaluation of the Safety, Tolerability and Efficacy of Odiparcil in the Prevention of Venous Thromboembolism Following Total Knee Replacement Surgery02/23/2006 - 02/22/2008 (PI)
GlaxoSmithKline, Inc.
Rheos Feasibility Trial01/12/2007 - 06/11/2007 (PI)
CVRx, Inc.
Dose-response relationship study of S42909 on leg ulcer healing after oral repeated administration..08/06/2018 - 08/05/2021 (PI)
Ilkos Therapeutic Inc
A multi-center prospective study to evaluate the safety and effectiveness of the VasQ external suppo11/01/2017 - 11/01/2020 (PI)
Laminate Medical Technologies Inc.
RANGER06/19/2017 - 06/19/2020 (PI)
Boston Scientific Corporation
BEST-CLI Trial-CCC-Lead09/17/2013 - 03/31/2019 (PI)
Brigham & Women's NIH-NHLBI5U01HL107352-05
Randomized Trial Comparing a Dual Action Pneumatic Compression System against Multi-Layer Bandagi…06/15/2016 - 06/14/2018 (PI)
ACTitouch Medical
Open versus Endovascular Popliteal Artery Aneurysm (OVER-PAR) Repair Trial11/01/2013 - 06/30/2017 (PI)
New England Society for Vascular Surgery
A Phase-3 Study of Curexcell12/04/2014 - 12/31/2016 (PI)
Macro Cure Ltd.
Evaluation of a Dual Action Pneumatic Compression System: Tolerance and Comfort in Patients with…12/31/2014 - 12/31/2015 (PI)
Tactile Medical
Vascular Physician Offer and Report (VAPOR) Trial12/01/2014 - 12/31/2015 (PI)
Dartmouth-Hitchcock Medical Center
TOPVENT02/01/2006 - 01/31/2007 (PI)
GlaxoSmithKline